By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


European Medicines Agency (EMA) 

7 Westferry Circus
Canary Wharf
London    E14 4HB  United Kingdom
Phone: 44-0-20-7523-7600 Fax: n/a



Company News
Actinium (ATNM.OB) Granted Orphan Designation From The EMA For Iomab-B 10/18/2016 10:11:02 AM
Teva (TEVA) Receives Positive Opinion From EMA'S Committee For Medicinal Products For Human Use (CHMP) To Extend Indication Of Trisenox For First Line Treatment Of Low- To Intermediate Risk Acute Promyelocytic Leukemia (APL) 10/17/2016 12:54:00 PM
Eiger Biopharma Announces Orphan Designation Of Exendin 9-39 For Treatment Of Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS) From EMA 10/17/2016 8:28:03 AM
Advanced Accelerator Applications Announces Positive EMA Opinion On Application For Somakit TOC 10/17/2016 7:08:12 AM
EMA Committee Conditionally Approves AbbVie (ABBV)'s Leukaemia Drug VENCLYXTO 10/14/2016 6:50:42 AM
Samsung Bioepis' Marketing Authorization Application For SB3 Trastuzumab Biosimilar Candidate Accepted For Review By EMA 10/4/2016 12:33:25 PM
Dipexium Pharmaceuticals (DPRX) Receives EMA Designation As A Small And Medium Enterprise 10/4/2016 8:12:19 AM
AB Science (AB.PA) Announces The Filing Of Masitinib In The Treatment Of Amyotrophic Lateral Sclerosis (ALS) To The EMA 9/30/2016 7:26:55 AM
Advanced Accelerator Applications Release: EMA Prematurely Announced Opinion On SomaKit TOC Kit Application 9/23/2016 8:04:57 AM
Ireland Makes Its Case to Be New Home for the EMA Following Brexit 9/23/2016 6:19:32 AM